Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Feb 24 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 582 | $485.11 | $282.3K | -6.9% | Open the original filing on SEC.gov |
| Feb 18 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 1,182 | $473.68 | $559.9K | -12.2% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,437 | $489.46 | $1.2M | -20.1% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 1,110 | $483.75 | $537K | -8.4% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | AGRANT◷ | 2,584 | — | — | +24.3% | Open the original filing on SEC.gov |
| Feb 13 | VRTX | Vertex Pharmaceuticals… | FTAX | 2,283 | $487.76 | $1.1M | -17.7% | Open the original filing on SEC.gov |
| Feb 11 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,021 | $460.43 | $930.5K | -13.5% | Open the original filing on SEC.gov |
| Feb 10 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 1,127 | $468.41 | $527.9K | -7.0% | Open the original filing on SEC.gov |